Last reviewed · How we verify
NCT06184620
Correlation Between Angle Closure Glaucoma Data and Lens Zonule Status
trial in Primary Angle Closure Glaucoma in 263 participants. Completed in 30 March 2023.
30 March 2023
Quick facts
| Lead sponsor | Guangfu Dang |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 263 |
| Start date | 1 December 2020 |
| Primary completion | 30 March 2023 |
| Estimated completion | 30 March 2023 |
| Sites | 1 location across China |
Conditions studied
- Primary Angle Closure Glaucoma — all drugs for Primary Angle Closure Glaucoma →
Sponsor
Guangfu Dang
Who can join
Adults 47 to 91, any sex, with Primary Angle Closure Glaucoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this observational study is to discuss the correlation between primary angle-closure glaucoma and the state of the suspended ligament of the lens and the pathogenesis of PACG by measuring the biological data of primary angle-closure glaucoma and observing its anatomical changes.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06184620
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Primary Angle Closure Glaucoma
Currently open trials in the same condition.
- NCT06952153 — Comparison of Phaco Surgery With Goniosynechialysis Versus Trabeculectomy in Glaucoma Treatment · NA · recruiting
- NCT05163951 — Trabeculectomy Versus Peripheral Iridectomy Plus Goniotomy in Advanced PACG · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06184620 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Guangfu Dang
- Last refreshed: 28 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06184620.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing